Recent 13F filings as of September 2025 show that 111 institutional investors hold a position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 30 Sep, 2025 | 8,459,220 | -209,307 | -2.41% | $24,531,739.00 |
| BML Capital Management, LLC | 30 Sep, 2025 | 7,473,963 | -135,849 | -1.79% | $21,674,493.00 |
| FMR LLC | 30 Sep, 2025 | 5,822,773 | 103,015 | 1.80% | $16,886,041.00 |
| TANG CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 4,826,200 | -63,000 | -1.29% | $13,995,980.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 4,709,275 | -177,946 | -3.64% | $13,656,897.00 |
| Bain Capital Life Sciences Investors, LLC | 30 Sep, 2025 | 2,485,638 | 0 | 0.00% | $7,208,350.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 1,899,737 | -25,836 | -1.34% | $5,510,507.00 |
| STATE STREET CORP | 30 Sep, 2025 | 1,783,976 | 7,575 | 0.43% | $5,173,530.00 |
| DIMENSIONAL FUND ADVISORS LP | 30 Sep, 2025 | 1,540,716 | 129,453 | 9.17% | $4,468,201.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 1,227,900 | -6,200 | -0.50% | $3,560,910.00 |
| ACADIAN ASSET MANAGEMENT LLC | 30 Sep, 2025 | 969,773 | 51,927 | 5.66% | $2,810.00 |
| TWO SIGMA ADVISERS, LP | 30 Sep, 2025 | 796,200 | 95,300 | 13.60% | $2,308,980.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 638,388 | -37,071 | -5.49% | $1,851,325.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 30 Sep, 2025 | 624,984 | -10,298 | -1.62% | $1,812,454.00 |
| JPMORGAN CHASE & CO | 30 Sep, 2025 | 616,851 | -35,810 | -5.49% | $1,788,869.00 |
| CM Management, LLC | 30 Sep, 2025 | 500,000 | 0 | 0.00% | $1,450,000.00 |
| Newtyn Management, LLC | 30 Sep, 2025 | 492,284 | -87,716 | -15.12% | $1,427,624.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 487,223 | 312,733 | 179.23% | $1,412,947.00 |
| TWO SIGMA INVESTMENTS, LP | 30 Sep, 2025 | 471,293 | 104,681 | 28.55% | $1,366,750.00 |
| Peapod Lane Capital LLC | 30 Sep, 2025 | 457,216 | 4,748 | 1.05% | $1,325,921.00 |